This image made available by NASA shows the planet Venus made with data from the Magellan spacecraft and Pioneer Venus Orbiter. On Wednesday, June 2, 2021, NASA’s new administrator, Bill Nelson, announced two new robotic missions to the solar system's hottest planet, during his first major address to employees. (NASA/JPL-Caltech via AP)
By Marcia Dunn
NASA is returning to sizzling Venus, our closest yet perhaps most overlooked neighbor, after decades of exploring other worlds.
The space agency's new administrator, Bill Nelson, announced two new robotic missions to the solar system's hottest planet, during his first major address to employees Wednesday.
“These two sister missions both aim to understand how Venus became an inferno-like world capable of melting lead at the surface," Nelson said.
One mission named DaVinci Plus will analyze the thick, cloudy Venusian atmosphere in an attempt to determine whether the inferno planet ever had an ocean and was possibly habitable. A small craft will plunge through the atmosphere to measure the gases.
It will be the first U.S.-led mission to the Venusian atmosphere since 1978.
The other mission, called Veritas, will seek a geologic history by mapping the rocky planet’s surface.
“It is astounding how little we know about Venus," but the new missions will give fresh views of the planet's atmosphere, made up mostly of carbon dioxide, down to the core, NASA scientist Tom Wagner said in a statement. “It will be as if we have rediscovered the planet.”
NASA’s top science official, Thomas Zurbuchen, calls it “a new decade of Venus.” Each mission — launching sometime around 2028 to 2030 — will receive $500 million for development under NASA’s Discovery program.
The missions beat out two other proposed projects, to Jupiter's moon Io and Neptune's icy moon Triton.
The U.S. and the former Soviet Union sent multiple spacecraft to Venus in the early days of space exploration. NASA's Mariner 2 performed the first successful flyby in 1962, and the Soviets' Venera 7 made the first successful landing in 1970.
In 1989, NASA used a space shuttle to send its Magellan spacecraft into orbit around Venus.
The European Space Agency put a spacecraft around Venus in 2006.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
